4.8 Article

Orthogonal near-infrared upconversion co-regulated site-specific O2 delivery and photodynamic therapy for hypoxia tumor by using red blood cell microcarriers

Journal

BIOMATERIALS
Volume 125, Issue -, Pages 90-100

Publisher

ELSEVIER SCI LTD
DOI: 10.1016/j.biomaterials.2017.02.017

Keywords

Upconversion; Hypoxia; Biological barriers; Photodynamic therapy

Funding

  1. NSFC [21322508, 21210004]
  2. China National Key Basic Research Program (973 Project) [2013CB934100]
  3. Program for New Century Excellent Talents in University (NCET)
  4. China Postdoctoral Science Foundation [2016T90333]
  5. Shanghai Yangfan Talent Program [17YF1401000]
  6. International Scientific Partnership Program ISPP at King Saud University [ISPP0100]

Ask authors/readers for more resources

Pre-existing hypoxia in tumors can result in an inadequate oxygen supply during photodynamic therapy (PDT), which in turn hampers photodynamic efficacy. To overcome this problem, we developed an orthogonal near-infrared upconversion controlled red blood cell (RBC) microcarriers to selectively deliver 02 in hypoxia area. Moreover, this RBC microcarriers are able to overcome a series of complex biological barriers which include transporting across the inflamed endothelium, evading mononuclear phagocyte system, reducing reticuloendothelial system uptake. Based on these abilities, RBC microcarriers have efficient tumors accumulation and are capable of delivery a large amount of O-2 for PDT under near infrared (NIR) irradiation to realize effective solid tumor eradication. (C) 2017 Elsevier Ltd. All rights reserved.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.8
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available